NCT05486507View on ClinicalTrials.gov

Health Benefits of Tart Cherry in Ulcerative Colitis

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

December 1, 2024

Conditions
Ulcerative Colitis
Interventions
DIETARY_SUPPLEMENT

Montmorency tart cherry

US grown Montmorency tart cherry 60ml per day for 6 weeks.

DIETARY_SUPPLEMENT

Placebo

Taste matched placebo.

Trial Locations (2)

PR1 2HE

University of Central Lancashire, Preston

Unknown

University of Hertfordshire, London

All Listed Sponsors
collaborator

University of Hertfordshire

OTHER

lead

University of Central Lancashire

OTHER

NCT05486507 - Health Benefits of Tart Cherry in Ulcerative Colitis | Biotech Hunter | Biotech Hunter